COVID-19: FDA Tells Test Makers How To Minimize Effects Of Variants
The US Food and Drug Administration has taken additional steps to ensure mutations of the COVID-19 virus do not negatively impact the efficacy of tests.
You may also be interested in...
The mixture in some faulty Abbott PCR tests could cause COVID-19 positive samples to flow into neighboring negative samples, resulting in false-positive results.
The US Food and Drug Administration has launched a new webpage dedicated to medical devices that incorporate augmented reality and virtual reality technologies. The agency has approved some 39 AR/VR devices.
The US Food and Drug Administration recently updated the labeling of Abiomed’s Impella RP System to reflect the latest results from a clinical study on the device. The FDA first approved the heart pump system in September 2017.